| Literature DB >> 26334268 |
Isabel O L Bacellar1, Tayana M Tsubone2, Christiane Pavani3, Mauricio S Baptista4.
Abstract
Photodynamic therapy (PDT) is a clinical modality used to treat cancer and infectious diseases. The main agent is the photosensitizer (PS), which is excited by light and converted to a triplet excited state. This latter species leads to the formation of singlet oxygen and radicals that oxidize biomolecules. The main motivation for this review is to suggest alternatives for achieving high-efficiency PDT protocols, by taking advantage of knowledge on the chemical and biological processes taking place during and after photosensitization. We defend that in order to obtain specific mechanisms of cell death and maximize PDT efficiency, PSes should oxidize specific molecular targets. We consider the role of subcellular localization, how PS photochemistry and photophysics can change according to its nanoenvironment, and how can all these trigger specific cell death mechanisms. We propose that in order to develop PSes that will cause a breakthrough enhancement in the efficiency of PDT, researchers should first consider tissue and intracellular localization, instead of trying to maximize singlet oxygen quantum yields in in vitro tests. In addition to this, we also indicate many open questions and challenges remaining in this field, hoping to encourage future research.Entities:
Keywords: cell death; photodynamic therapy; photooxidation; photosensitization; subcellular localization
Mesh:
Substances:
Year: 2015 PMID: 26334268 PMCID: PMC4613217 DOI: 10.3390/ijms160920523
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Main routes and initial products of singlet oxygen and radical mediated photooxidations (for details on the products formed, refer to citations in the main text). Abbreviations: PS: photosensitizer; ISC: intersystem crossing; A: substrate for electron transfer reactions.
Figure 2Biological outcomes of photodynamic therapy (PDT) associated with the amount of reactive species that are generated and possible targets of photooxidation. Note that it is not necessary to damage all targets together to trigger cell death. (A) High PDT-doses in organelles and photodamage of plasma membrane cause ATP depletion, resulting in non-programmed cell death (necrosis); (B) production of reactive species in mitochondria and/or damage to protein B-cell lymphoma 2 (Bcl-2) causes the release of cytochrome c and other apoptogenic factors, which classically trigger the caspases cascade, resulting in apoptosis. Photodamaging endoplasmic reticulum (ER) and lysosomes can also converge to mitochondrial damage, resulting in apoptosis; (C) low PDT-doses in organelles (mitochondria, ER and lysosomes) may activate autophagic process in an unbalanced manner (too much induction or flux inhibition), resulting in autophagic cell death. The inhibition of the mammalian target of rapamycin (mTOR) complex by photooxidation can also trigger autophagy as a cell death pathway.
Subcellular localization, biological consequences and cell death mechanisms induced by photosensitizers (PSes).
| Photosensitizer (PS) | Subcellular Localization | Biological Consequences | Cell Death Mechanism | References |
|---|---|---|---|---|
| 9-Capronyloxytetrakis-(methoxyethyl)porphycene (CPO) | Endoplasmic reticulum (ER) | B-cell lymphoma 2 (Bcl-2) loss and release of Ca2+ | Apoptosis and autophagy | [ |
| Sulfonated aluminum phthalocyanines (AlPcS2-4) | Lysosomes | Photodamage to mammalian target of rapamycin (mTOR) signaling network and release of lysosomal proteases, which activate caspase 3 | ND | [ |
| Benzoporphyrin (BPD, Verteporfin) | Mitochondria | Decreases B-cell lymphoma-extra large (Bcl-xL) and increases the Bcl-2 associated X protein (Bax)/Bcl-xL ratio | Apoptosis | [ |
| Cationic porphyrins | Plasma membrane and mitochondria | Plasma membrane disruption and mitochondrial inner membrane permeabilization, causing release of cytochrome
| Necrosis and apoptosis | [ |
| Cationic zinc(II) phthalocyanines | Mitochondria | Destruction of the inner mitochondrial membrane | Apoptosis | [ |
| Chlorophyllin e4 | Mitochondria and lysosomes | ND | Apoptosis and autophagy | [ |
| Hypericin | ER | Loss of SERCA (sarco/endoplasmic reticulum Ca2+-ATPase) protein levels causing ER-Ca2+ depletion | Apoptosis and autophagy | [ |
| Methylene blue (MB) | Mitochondria and lysosomes | Reduction of mitochondrial membrane potential and downregulation of the anti-apoptotic proteins Bcl-2 | Apoptosis | [ |
| mTHPC, Foscan® | Mitochondria, golgi apparatus and ER | Photodamage to Bcl-2 protein and release of cytochrome | Apoptosis | [ |
| Lysosomes | Release of lysosomal proteases that cleave BH3-interacting domain death agonist (Bid) | Apoptosis | [ | |
| Photofrin® | Plasma membrane and mitochondria | Plasma membrane disruption and mitochondrial inner membrane permeabilization, causing release of cytochrome | Necrosis and apoptosis | [ |
| Rose bengal (RB) | Golgi apparatus | ND | Necrosis, apoptosis and autophagy | [ |
| Silicon phthalocyanine (Pc4) | Mitochondria, ER and Golgi | Photodamage to Bcl-2 protein | Apoptosis | [ |
| Tetrakis (p-sulfonatophenyl) porphyrin (TPPS4) | Lysosomes | Release of proteases causing cathepsin-mediated cleavage of Bid and inhibition of autolysosome formation | Apoptosis and autophagy | [ |
ND: Not determined.
Figure 3Possible outcomes of the interaction between photosensitizers (PSes) and binding sites of macromolecules or particles, considering triplet excited states deactivation pathways: (A) stabilization of the monomeric form of the PS and formation of singlet oxygen by energy transfer; (B) stabilization of the dimeric species, favoring the dye–dye mechanism; and (C) binding of the PS to a pocket inaccessible to oxygen, raising the probability of electron transfer pathways.
Figure 4Proposed main steps that should happen with the photosensitizer (PS) in order to achieve cell death.